Built on the values of Confidence, Care and Science, KeyCi is rooted in dermatological research and sustainability
Iberia Pharmaceuticals has launched KeyCi, a science-backed skincare brand designed for modern consumers aged 18–45. KeyCi offers high-performance, dermatologically tested products that are vegan, cruelty-free, alcohol-free, paraben-free and FDA approved. Developed by dermatologists and supported by pharma-grade R&D, KeyCi’s range of four products aims to bridge the gap between daily skincare and clinical-grade performance with formulations that address Indian skin specifically.
KeyCi offerings will be on e-commerce platforms. Gender-neutral and suitable for all skin types, these products are founded on the core principles of Confidence, Care, and Science. Beyond formulations, KeyCi reflects Iberia’s values of sustainability and conscious production. Packaging has been designed with recyclable materials and minimal plastic to reduce waste, ensuring premium skincare aligns with eco-friendly living. From responsible sourcing and green materials to research-based innovation, each KeyCi product is a testament to the brand’s commitment to mindful beauty.
“KeyCi has been in development for several years, with Iberia’s in-house research team working closely with dermatologists and clinical partners to create products that are safe, effective and suited to local conditions. Unlike global products adapted for India, KeyCi has been meticulously developed from the ground up, with formulations precisely designed to address the unique climate and lifestyle requirements of Indian consumers, said Nitin Jain, Founder, Iberia Pharmaceuticals.
“Our new product line represents the next step in our journey as we aim to expand our presence significantly. With this launch, KeyCi delivers affordable luxury, premium-quality skincare that is safe, ethical and accessible. All formulations are dermatologically tested and free from alcohol, parabens, sulfates and artificial fragrances,” said Saurav Ojha, Co-Founder Iberia Pharmaceuticals.
Iberia Pharmaceuticals has established itself as a trusted name in pharma-grade skincare through brands such as Sesderma, Dermpix, Noreva, Metacare and Mediderma. With KeyCi, Iberia extends this legacy to a new generation of conscious consumers seeking products that are both effective and ethical.
The brand also mirrors Iberia’s broader expansion strategy. With an investment of Rs 70 crore, Iberia is setting up a new manufacturing facility in Haryana that will produce over 12 million units annually and create more than 600 jobs.
